EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Changing Epidemiology of Myocarditis in Australia: A Population-Based Cohort Study

Timothy Nathan Kwan, Gemma Kwan, David Brieger, Leonard Kritharides iD, Vincent Chow, Austin Chin Chwan Ng iD

Journal of Clinical Medicine · 24.11.2024 · 13 (23) · 7111

DOI: 10.3390/jcm13237111 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.11.2024. Verfasst von Timothy Nathan Kwan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Concord Hospital, The University of Sydney, 1 Hospital Road, Concord, Sydney, NSW 2139, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myocarditis is a serious disease that has drawn increasing attention due to its association with COVID-19 and vaccination. This study investigates the epidemiology of myocarditis beyond the COVID-19 pandemic, including its incidence and outcomes over time.

Methods

We analyzed the population-wide retrospective data from the Admitted-Patient-Data-Collection database of patients admitted to hospitals in New South Wales (NSW), Australia, with a diagnosis of myocarditis from 2001 to 2022. The incidence of myocarditis, changing classification of myocarditis over time, and complications of myocarditis over time were all calculated.

Results

There were 4071 patients diagnosed with their first episode of myocarditis, with a median age of 42 years old, and 66% were male. The incidence of myocarditis in NSW has tripled over 20-years to 8.3 per-100,000-persons by 2022. Reactive myocarditis (i.e., myocarditis within 30-days of a respiratory or digestive illness) accounted for 38% of first presentations of myocarditis. Post COVID-19 myocarditis, a subset of reactive myocarditis, accounted for 42% of myocarditis admissions since the onset of the COVID-19 pandemic in Australia. Eight percent of patients had a background history of malignancy, and 6% had a history of autoimmune disease. In-hospital mortality was 4.5% during the entire study period but has been falling by 11% per year. During follow up, most readmissions for myocarditis occurred within 6-months; with 5.1% recurrence at 6-months compared to only 6.7% at 5-years.

Conclusions

Myocarditis is an important condition with increasing incidence in Australia and with markedly changing characteristics in the pandemic and post pandemic era.

Schlagwörter

Stichwörter der Autor:innen

AustraliaCOVID-19epidemiologyheart failuremyocarditis

Autor:innen und Institutionen

  • Department of Cardiology, Concord Hospital, The University of Sydney, 1 Hospital Road, Concord, Sydney, NSW 2139, Australia.
  • Department of Immunology, Royal Prince Alfred Hospital, The University of Sydney, 50 Missenden Rd., Camperdown, Sydney, NSW 2050, Australia.

ORCID-Profile: Leonard Kritharides, Austin Chin Chwan Ng

Zitieren

APA

Kwan, T. N., Kwan, G., Brieger, D., Kritharides, L., Chow, V., & Ng, A. C. C. (2024). Changing Epidemiology of Myocarditis in Australia: A Population-Based Cohort Study. Journal of Clinical Medicine, 13(23), 7111. https://doi.org/10.3390/jcm13237111

Vancouver

Kwan TN, Kwan G, Brieger D, Kritharides L, Chow V, Ng ACC. Changing Epidemiology of Myocarditis in Australia: A Population-Based Cohort Study. Journal of Clinical Medicine. 2024;13(23):7111. doi:10.3390/jcm13237111

BibTeX
@article{Kwan2024,
  author = {Kwan, Timothy Nathan and Kwan, Gemma and Brieger, David and Kritharides, Leonard and Chow, Vincent and Ng, Austin Chin Chwan},
  title = {Changing Epidemiology of Myocarditis in Australia: A Population-Based Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {23},
  pages = {7111},
  doi = {10.3390/jcm13237111}
}
Kostenlos starten →